JPWO2020252589A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020252589A5
JPWO2020252589A5 JP2021574974A JP2021574974A JPWO2020252589A5 JP WO2020252589 A5 JPWO2020252589 A5 JP WO2020252589A5 JP 2021574974 A JP2021574974 A JP 2021574974A JP 2021574974 A JP2021574974 A JP 2021574974A JP WO2020252589 A5 JPWO2020252589 A5 JP WO2020252589A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
independently
alkynyl
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574974A
Other languages
English (en)
Japanese (ja)
Other versions
JP7416096B2 (ja
JP2022537305A5 (https=
JP2022537305A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050854 external-priority patent/WO2020252589A1/en
Publication of JP2022537305A publication Critical patent/JP2022537305A/ja
Publication of JPWO2020252589A5 publication Critical patent/JPWO2020252589A5/ja
Publication of JP2022537305A5 publication Critical patent/JP2022537305A5/ja
Application granted granted Critical
Publication of JP7416096B2 publication Critical patent/JP7416096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021574974A 2019-06-20 2020-06-19 核酸送達のためのイオン化可能な脂質 Active JP7416096B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962864064P 2019-06-20 2019-06-20
US62/864,064 2019-06-20
US201962877536P 2019-07-23 2019-07-23
US62/877,536 2019-07-23
US202063009104P 2020-04-13 2020-04-13
US63/009,104 2020-04-13
PCT/CA2020/050854 WO2020252589A1 (en) 2019-06-20 2020-06-19 Ionizable lipids for nucleic acid delivery

Publications (4)

Publication Number Publication Date
JP2022537305A JP2022537305A (ja) 2022-08-25
JPWO2020252589A5 true JPWO2020252589A5 (https=) 2023-06-26
JP2022537305A5 JP2022537305A5 (https=) 2023-06-26
JP7416096B2 JP7416096B2 (ja) 2024-01-17

Family

ID=74036881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574974A Active JP7416096B2 (ja) 2019-06-20 2020-06-19 核酸送達のためのイオン化可能な脂質

Country Status (9)

Country Link
US (2) US12503432B2 (https=)
EP (1) EP3986866B1 (https=)
JP (1) JP7416096B2 (https=)
KR (1) KR102568997B1 (https=)
CN (1) CN114746401B (https=)
CA (1) CA3143577C (https=)
DK (1) DK3986866T3 (https=)
ES (1) ES2973521T3 (https=)
WO (1) WO2020252589A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166783B (zh) 2018-10-09 2024-10-11 不列颠哥伦比亚大学 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法
CA3112837A1 (en) * 2018-10-19 2020-04-23 Translate Bio, Inc. Pumpless encapsulation of messenger rna
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
IL303195A (en) 2020-11-25 2023-07-01 Akagera Medicines Inc Lipid nanoparticles for delivery of nucleic acids and related methods of use
CN114149337B (zh) * 2021-07-07 2022-04-29 天津键凯科技有限公司 一种用于核酸递送的新型可电离脂质及其lnp组合物
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
KR20230017730A (ko) 2021-07-27 2023-02-06 에스케이바이오사이언스(주) 단백질 발현을 위한 mRNA와 이를 위한 주형
CN115772089B (zh) * 2021-09-07 2025-06-10 广州谷森制药有限公司 阳离子脂质化合物
US11510975B1 (en) 2021-11-29 2022-11-29 Replicate Bioscience, Inc. Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune responses
EP4531819A2 (en) 2022-05-25 2025-04-09 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
WO2024006863A1 (en) 2022-06-30 2024-01-04 Precision NanoSystems ULC Lipid nanoparticle formulations for vaccines
AU2023393613A1 (en) 2022-12-12 2025-06-19 Global Life Sciences Solutions Canada Ulc Lipid nanoparticles lyophilization methods and compositions
KR102921785B1 (ko) * 2022-12-19 2026-02-03 주식회사 녹십자 핵산 전달용 사이클로알칸계 지질 화합물 및 이를 포함하는 지질 나노입자
IL321425A (en) 2022-12-23 2025-08-01 Biontech Delivery Tech Gmbh compound
US12311033B2 (en) 2023-05-31 2025-05-27 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
AU2023457271A1 (en) 2023-06-28 2025-12-18 Global Life Sciences Solutions Canada Ulc Lipid nanoparticle formulations for cell therapy and related methods
CN121712495A (zh) 2023-08-21 2026-03-20 环球生命科学解决方案加拿大有限公司 用于离子流脂质纳米颗粒的制造方法和装置
WO2025049579A1 (en) 2023-08-31 2025-03-06 Global Life Sciences Solutions Canada Ulc Intranasal formulation for pulmonary delivery of nanoparticles, compositions, uses, and manufacturing methods thereof
WO2025219528A1 (en) 2024-04-17 2025-10-23 Global Life Sciences Solutions Canada Ulc Non-destructive plasmid delivery to immune cells
WO2025219491A1 (en) 2024-04-17 2025-10-23 Global Life Sciences Solutions Canada Ulc Method and composition for hdr template dna delivery
WO2025224267A1 (en) 2024-04-25 2025-10-30 Global Life Sciences Solutions Canada Ulc Method for producing a liquid composition including a nanoparticle, and formulation thereof
WO2026035680A1 (en) 2024-08-06 2026-02-12 Kernal Biologics, Inc. Compositions and methods for delivery of agents
WO2026052854A1 (en) 2024-09-09 2026-03-12 Global Life Sciences Solutions Canada Ulc 3-component lipid nanoparticle compositions, uses, and manufacturing methods thereof
WO2026052844A1 (en) 2024-09-09 2026-03-12 Global Life Sciences Solutions Canada Ulc 3-component lipid nanoparticle compositions, uses, and manufacturing methods thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1539268A (en) 1976-12-23 1979-01-31 Ici Ltd Prostane derivatives
JPH0822830B2 (ja) 1988-10-19 1996-03-06 長谷川香料株式会社 2(z)−ペンテニル置換シクロペンタン類およびその新規中間体
JP2743198B2 (ja) 1989-09-26 1998-04-22 長谷川香料株式会社 シクロペンタン類
US5753613A (en) 1994-09-30 1998-05-19 Inex Pharmaceuticals Corporation Compositions for the introduction of polyanionic materials into cells
US6734171B1 (en) 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers
EP1412065A2 (en) 2001-07-27 2004-04-28 President And Fellows Of Harvard College Laminar mixing apparatus and methods
WO2008109238A1 (en) 2007-03-02 2008-09-12 Janssen Pharmaceutica N.V. Substituted cyclopentyl piperidine ccr2 antagonists
WO2009086558A1 (en) * 2008-01-02 2009-07-09 Tekmira Pharmaceuticals Corporation Improved compositions and methods for the delivery of nucleic acids
HUE037082T2 (hu) 2008-11-10 2018-08-28 Arbutus Biopharma Corp Új lipidek és készítmények terápiás hatóanyagok szállítására
MX342785B (es) 2009-06-10 2016-10-12 Alnylam Pharmaceuticals Inc Formulacion mejorada de lipido.
CA2816925C (en) 2009-11-04 2023-01-10 The University Of British Columbia Nucleic acid-containing lipid particles and related methods
JP2014001142A (ja) 2010-10-05 2014-01-09 Astellas Pharma Inc シクロアルカン化合物
CA2824526C (en) 2011-01-11 2020-07-07 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
WO2012108397A1 (ja) 2011-02-08 2012-08-16 第一三共株式会社 新規脂質
EP3069785A1 (en) 2011-10-25 2016-09-21 The University Of British Columbia Limit size lipid nanoparticles and related methods
CA2906732C (en) 2013-03-15 2023-08-08 The University Of British Columbia Lipid nanoparticles for transfection and related methods
AU2016385135B2 (en) 2016-01-06 2022-02-17 The University Of British Columbia Bifurcating mixers and methods of their use and manufacture
EP3481539A4 (en) 2016-07-06 2020-02-26 Precision Nanosystems Inc INTELLIGENT MICROFLUIDIC MIXING INSTRUMENT AND CARTRIDGES
WO2018232502A1 (en) * 2017-06-20 2018-12-27 Rjh Biosciences Inc. Transfection reagents for delivery of nucleic acids
WO2019182527A1 (en) 2018-03-21 2019-09-26 T.C. Istanbul Medipol Universitesi Methyl jasmonate derivatives as possible drug candidates for use in treatment of cancer

Similar Documents

Publication Publication Date Title
JPWO2020252589A5 (https=)
JPWO2021000041A5 (https=)
MX2024007720A (es) Lipidos para la administracion de agentes activos en nanoparticulas lipidicas.
JP2017522376A5 (https=)
JPWO2020081938A5 (https=)
MX2025002671A (es) Lipidos para uso en formulaciones de nanoparticulas de lipidos
JP6270848B2 (ja) ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下
JP2018524339A5 (https=)
JP2009523841A5 (https=)
RU93058253A (ru) Соединения-антибиотики, способы их получения, промежуточные соединения, фармкомпозиция, способ лечения
KR920009796A (ko) 3-아미도인돌릴 유도체
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
KR950700265A (ko) 고지혈증 치료에 유용한 벤조티아제핀 화합물(hypolipidaemic ben zothiazepine compounds)
JP2012507522A5 (https=)
JPWO2023099592A5 (https=)
JP2004517099A5 (https=)
JP2004517843A5 (https=)
JPWO2023114943A5 (https=)
MX2025013218A (es) Lipidos para usarse en formulaciones de nanoparticulas de lipido
RU99127433A (ru) Эрголиновые производные и их применение в качестве антагонистов рецепторов соматостатина
JPWO2022152821A5 (https=)
JPWO2023114944A5 (https=)
JPH02255652A (ja) ベンゼンスルホンアミド類およびその製造方法
JP3131693B2 (ja) 眼疾患を処置するための5―メチル―イソオキサゾール―4―カルボン酸アニリド類または2―ヒドロキシエチリデン―シアノ酢酸アニリド類含有医薬組成物
JPWO2023091787A5 (https=)